Dual-seq transcriptomics reveals the battle for iron during Pseudomonas aeruginosa acute murine pneumonia

Scientific Reports

Volumn 6, Issue 1, 2016, Pages

  Damron, F Heath ^a   Oglesby Sherrouse, Amanda G ^b,c   Wilks, Angela ^b,c   Barbier, Mariette ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; CYTOKINE; IRON; PROTEOME; RNA; TRANSCRIPTOME; UNTRANSLATED RNA;

ANIMAL; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PATHOLOGY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEQUENCE ANALYSIS; VIRULENCE;

ANIMALS; CYTOKINES; GENE EXPRESSION REGULATION, BACTERIAL; HOST-PATHOGEN INTERACTIONS; IRON; LUNG; MACROPHAGES; MICE; PROTEOME; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RNA; RNA, BACTERIAL; RNA, UNTRANSLATED; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME; VIRULENCE;

EID: 85047925317     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39172     Document Type: Article

References (89)

1. Sadikot, R. T., Blackwell, T. S., Christman, J. W. & Prince, A. S. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171, 1209–23 (2005).
2. Centers for Disease Control and Prevention, C. D. C. Antibiotic resistance threats in the United States, 2013. Atlanta CDC (2013).
3. Aliaga, L., Mediavilla, J. D. & Cobo, F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 51, 615–619 (2002).
4. Behrends, V. et al. Metabolic adaptations of Pseudomonas aeruginosa during cystic fibrosis chronic lung infections. Env. Microbiol 15, 398–408 (2013).
5. Mathee, K. et al. Dynamics of Pseudomonas aeruginosa genome evolution. Proc. Natl. Acad. Sci. USA 105, 3100–5 (2008).
6. Wolfgang, M. C. et al. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci USA 100, 8484–8489 (2003).
7. Barbier, M. et al. From the environment to the host: re-wiring of the transcriptome of Pseudomonas aeruginosa from 22 degrees C to 37 degrees C. PLoS One 9, e89941 (2014).
8. Bielecki, P. et al. In-vivo expression profiling of Pseudomonas aeruginosa infections reveals niche-specific and strain-independent transcriptional programs. PLoS One 6, e24235 (2011).
9. Lavoie, E. G., Wangdi, T. & Kazmierczak, B. I. Innate immune responses to Pseudomonas aeruginosa infection. Microbes Infect 13, 1133–1145 (2011).
10. Son, M. S., Matthews, W. J., Kang, Y., Nguyen, D. T. & Hoang, T. T. In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect. Immun. 75, 5313–24 (2007).
11. Turner, K. H., Everett, J., Trivedi, U., Rumbaugh, K. P. & Whiteley, M. Requirements for Pseudomonas aeruginosa acute burn and chronic surgical wound infection. PLoS Genet 10, e1004518 (2014).
12. Campodonico, V. L., Gadjeva, M., Paradis-Bleau, C., Uluer, A. & Pier, G. B. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med 14, 120–133 (2008).
13. Hartl, D. et al. Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 11, 363–382 (2012).
14. Williams, B. J., Dehnbostel, J. & Blackwell, T. S. Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15, 1037–1056 (2010).
15. Barber, M. F. & Elde, N. C. Nutritional immunity. Escape from bacterial iron piracy through rapid evolution of transferrin. Science. 346, 1362–1366 (2014).
16. Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet 47, 57–64 (2015).
17. Marvig, R. L. et al. Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. MBio 5, e00966–14 (2014).
18. Westermann, A. J. et al. Dual RNA-seq unveils noncoding RNA functions in host–pathogen interactions. Nature 529, 496–501 (2016).
19. Westermann, A. J., Gorski, S. A. & Vogel, J. Dual RNA-seq of pathogen and host. Nat Rev Microbiol 10, 618–630 (2012).
20. Schulze, S., Henkel, S. G., Driesch, D., Guthke, R. & Linde, J. Computational prediction of molecular pathogen-host interactions based on dual transcriptome data. Front. Microbiol. 6, 65 (2015).
21. Cloney, R. Microbial genetics: Dual RNA-seq for host-pathogen transcriptomics. Nat. Rev. Genet. 17, 126–7 (2016).
22. Pittman, K. J., Aliota, M. T. & Knoll, L. J. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection. BMC Genomics 15, 806 (2014).
23. Tian, L. et al. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci USA 102, 13544–13549 (2005).
24. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457–62 (2016).
25. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25–29 (2000).
26. Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41, D808–15 (2013).
27. Macdonald, I. A. & Kuehn, M. J. Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa. J Bacteriol 195, 2971–2981 (2013).
28. Tan, T. T., Morgelin, M., Forsgren, A. & Riesbeck, K. Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J Infect Dis 195, 1661–1670 (2007).
29. Vidakovics, M. L. et al. B cell activation by outer membrane vesicles-a novel virulence mechanism. PLoS Pathog 6, e1000724 (2010).
30. Kulp, A. & Kuehn, M. J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 64, 163–184 (2010).
31. Damron, F. H. et al. Analysis of the Pseudomonas aeruginosa regulon controlled by the sensor kinase KinB and sigma factor RpoN. J Bacteriol 194, 1317–1330 (2012).
32. KING, E. O., WARD, M. K. & RANEY, D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J. Lab. Clin. Med. 44, 301–7 (1954).
33. Sonnleitner, E., Abdou, L. & Haas, D. Small RNA as global regulator of carbon catabolite repression in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 106, 21866–21871 (2009).
34. Sonnleitner, E. & Haas, D. Small RNAs as regulators of primary and secondary metabolism in Pseudomonas species. Appl. Microbiol. Biotechnol. 91, 63–79 (2011).
35. Sonnleitner, E., Romeo, A. & Bläsi, U. Small regulatory RNAs in Pseudomonas aeruginosa. RNA Biol. 9, 364–71 (2012).
36. Sonnleitner, E. & Bläsi, U. Regulation of Hfq by the RNA CrcZ in Pseudomonas aeruginosa carbon catabolite repression. PLoS Genet. 10, e1004440 (2014).
37. Shaver, C. M. & Hauser, A. R. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun 72, 6969–6977 (2004).
38. Mougous, J. D. et al. A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus. Science 312, 1526–30 (2006).
39. Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I. & Iglewski, B. H. Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons: effects of growth phase and environment. J Bacteriol 185, 2080–2095 (2003).
40. Caballero, A., Thibodeaux, B., Marquart, M., Traidej, M. & O’Callaghan, R. Pseudomonas keratitis: protease IV gene conservation, distribution, and production relative to virulence and other Pseudomonas proteases. Invest Ophthalmol Vis Sci 45, 522–530 (2004).
41. Bielecki, P., Glik, J., Kawecki, M. & Martins dos Santos, V. a P. Towards understanding Pseudomonas aeruginosa burn wound infections by profiling gene expression. Biotechnol. Lett. 30, 777–90 (2008).
42. Jaffar-Bandjee, M. C. et al. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis in patients chronically infected by Pseudomonas aeruginosa. J. Clin. Microbiol. 33, 924–9 (1995).
43. Hogardt, M. & Heesemann, J. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung. Curr. Top. Microbiol. Immunol. 358, 91–118 (2013).
44. Goodman, A. L. et al. A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev. Cell 7, 745–54 (2004).
45. Lapouge, K., Schubert, M., Allain, F. H.-T. & Haas, D. Gac/Rsm signal transduction pathway of gamma-proteobacteria: from RNA recognition to regulation of social behaviour. Mol. Microbiol. 67, 241–53 (2008).
46. Lory, S., Merighi, M. & Hyodo, M. Multiple activities of c-di-GMP in Pseudomonas aeruginosa. Nucleic Acids Symp. Ser. (Oxf). 51–2 (2009).
47. Bordi, C. et al. Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis. Mol Microbiol 76, 1427–1443 (2010).
48. Goodman, A. L. et al. Direct interaction between sensor kinase proteins mediates acute and chronic disease phenotypes in a bacterial pathogen. Genes Dev. 23, 249–59 (2009).
49. Ramphal, R. et al. Control of Pseudomonas aeruginosa in the lung requires the recognition of either lipopolysaccharide or flagellin. J Immunol 181, 586–592 (2008).
50. Raoust, E. et al. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One 4, e7259 (2009).
51. Skerrett, S. J., Wilson, C. B., Liggitt, H. D. & Hajjar, A. M. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L312–22 (2007).
52. Ernst, R. K. et al. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J. Endotoxin Res. 9, 395–400 (2003).
53. Erridge, C., Pridmore, A., Eley, A., Stewart, J. & Poxton, I. R. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J. Med. Microbiol. 53, 735–40 (2004).
54. Pene, F. et al. Toll-like receptor 2 deficiency increases resistance to Pseudomonas aeruginosa pneumonia in the setting of sepsis-induced immune dysfunction. J Infect Dis 206, 932–942 (2012).
55. Faure, K. et al. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins. Respir. Res. 5, 1 (2004).
56. Adamo, R., Sokol, S., Soong, G., Gomez, M. I. & Prince, A. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol 30, 627–634 (2004).
57. Soong, G., Reddy, B., Sokol, S., Adamo, R. & Prince, A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest 113, 1482–1489 (2004).
58. Lau, G. W. et al. The Drosophila melanogaster toll pathway participates in resistance to infection by the gram-negative human pathogen Pseudomonas aeruginosa. Infect. Immun. 71, 4059–66 (2003).
59. Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B. & Miller, S. I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3, 354–9 (2002).
60. Sutterwala, F. S. et al. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med 204, 3235–3245 (2007).
61. Wu, L. et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science 309, 774–7 (2005).
62. Peek, M. E., Bhatnagar, A., McCarty, N. A. & Zughaier, S. M. Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition. Interdiscip. Perspect. Infect. Dis. 2012, 843509 (2012).
63. Brandel, J. et al. Pyochelin, a siderophore of Pseudomonas aeruginosa: physicochemical characterization of the iron(III), copper(II) and zinc(II) complexes. Dalton Trans. 41, 2820–34 (2012).
64. Cornelis, P. Iron uptake and metabolism in pseudomonads. Appl Microbiol Biotechnol 86, 1637–1645 (2010).
65. Redly, G. A. & Poole, K. Pyoverdine-mediated regulation of FpvA synthesis in Pseudomonas aeruginosa: involvement of a probable extracytoplasmic-function sigma factor, FpvI. J Bacteriol 185, 1261–1265 (2003).
66. Redly, G. A. & Poole, K. FpvIR control of fpvA ferric pyoverdine receptor gene expression in Pseudomonas aeruginosa: demonstration of an interaction between FpvI and FpvR and identification of mutations in each compromising this interaction. J Bacteriol 187, 5648–5657 (2005).
67. Meyer, J. M., Neely, A., Stintzi, A., Georges, C. & Holder, I. A. Pyoverdin is essential for virulence of Pseudomonas aeruginosa. Infect Immun 64, 518–523 (1996).
68. Takase, H., Nitanai, H., Hoshino, K. & Otani, T. Impact of siderophore production on Pseudomonas aeruginosa infections in immunosuppressed mice. Infect Immun 68, 1834–1839 (2000).
69. Ochsner, U. A., Johnson, Z. & Vasil, M. L. Genetics and regulation of two distinct haem-uptake systems, phu and has, In Pseudomonas aeruginosa. Microbiology 146 (Pt 1), 185–198 (2000).
70. Smith, A. D. & Wilks, A. Differential contributions of the outer membrane receptors PhuR and HasR to heme acquisition in Pseudomonas aeruginosa. J Biol Chem 290, 7756–7766 (2015).
71. Lansky, I. B. et al. The cytoplasmic heme-binding protein (PhuS) from the heme uptake system of Pseudomonas aeruginosa is an intracellular heme-trafficking protein to the delta-regioselective heme oxygenase. J Biol Chem 281, 13652–13662 (2006).
72. O’Neill, M. J. & Wilks, A. The P. aeruginosa heme binding protein PhuS is a heme oxygenase titratable regulator of heme uptake. ACS Chem. Biol. 8, 1794–802 (2013).
73. Cornelis, P. & Dingemans, J. Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Cell Infect Microbiol 3, 75 (2013).
74. Turner, K. H., Wessel, A. K., Palmer, G. C., Murray, J. L. & Whiteley, M. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc. Natl. Acad. Sci. 112, 4110–4115 (2015).
75. Zhao, K., Deng, X., He, C., Yue, B. & Wu, M. Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway. Infect Immun 81, 4509–4518 (2013).
76. Blohmke, C. J. et al. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J Immunol 180, 7764–7773 (2008).
77. Schnare, M., Rollinghoff, M. & Qureshi, S. Toll-like receptors: sentinels of host defence against bacterial infection. Int Arch Allergy Immunol 139, 75–85 (2006).
78. Hood, M. I. & Skaar, E. P. Nutritional immunity: transition metals at the pathogen-host interface. Nat. Rev. Microbiol. 10, 525–37 (2012).
79. Cornelissen, C. N. & Sparling, P. F. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol 14, 843–850 (1994).
80. Oglesby-Sherrouse, A. G. & Vasil, M. L. Characterization of a Heme-Regulated Non-Coding RNA Encoded by the prrF Locus of. PLoS One 5, e9930 (2010).
81. De Vos, D. et al. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175, 384–388 (2001).
82. Martin, L. W., Reid, D. W., Sharples, K. J. & Lamont, I. L. Pseudomonas siderophores in the sputum of patients with cystic fibrosis. Biometals 24, 1059–1067 (2011).
83. Frisk, A. et al. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect. Immun. 72, 5433–8 (2004).
84. Kirienko, N. V., Ausubel, F. M. & Ruvkun, G. Mitophagy confers resistance to siderophore-mediated killing by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 112, 1821–6 (2015).
85. Konings, A. F. et al. Pseudomonas aeruginosa uses multiple pathways to acquire iron during chronic infection in cystic fibrosis lungs. Infect Immun 81, 2697–2704 (2013).
86. Nguyen, A. T. et al. Adaptation of iron homeostasis pathways by a Pseudomonas aeruginosa pyoverdine mutant in the cystic fibrosis lung. J Bacteriol 196, 2265–2276 (2014).
87. Wurst, J. M. et al. Identification of inhibitors of PvdQ, an enzyme involved in the synthesis of the siderophore pyoverdine. ACS Chem Biol 9, 1536–1544 (2014).
88. Möllmann, U., Heinisch, L., Bauernfeind, A., Köhler, T. & Ankel-Fuchs, D. Siderophores as drug delivery agents: application of the “Trojan Horse” strategy. Biometals 22, 615–24 (2009).
89. Robinson, M. D. & Smyth, G. K. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9, 321–32 (2008).